A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems

NCT ID: NCT02738840

Last Updated: 2021-06-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-21

Study Completion Date

2020-12-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A post market study evaluating the safety of the Prodigy MRI and Proclaim Elite MR conditional Spinal Cord Stimulator (SCS) systems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will be performed as an international, multicenter, prospective and single-arm design. The study will be conducted as a Post Market Clinical Follow Up (PMCF) study and the results will be submitted to the Notified Body: BSI Group (BSI).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

International, multicenter, prospective, and single-arm design
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prodigy MRI or Proclaim Elite MR

The Prodigy MRI system is only MR conditional for scans of the head and extremities (upper except shoulder, lower except hip).

The Proclaim Elite system is MR conditional for scans of the head, extremities or any other body part.

Group Type EXPERIMENTAL

MRI scan

Intervention Type PROCEDURE

MRI scan

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI scan

MRI scan

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has been implanted with a Prodigy MRI or Proclaim Elite MR conditional SCS system
* Patient will receive an MRI scan in compliance with the Instructions For Use (IFU) for the implanted MR conditional SCS system
* Patient is ≥ 18 years of age
* Patient must be willing and able to comply with study requirements
* Patient must indicate his/her understanding of the study and willingness to participate by signing an appropriate Informed Consent Form

Exclusion Criteria

* Patient has another implanted device (active or passive) that prohibits safe scanning
* Patient has previously experienced an MRI scan-related adverse event
* Patient is currently enrolled in another Abbott study that collects MRI safety data
* Patient is incapacitated, is unable to read or write, or is pregnant or breastfeeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicole Harbert

Role: STUDY_DIRECTOR

Abbott

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Napa Valley Orthopedic Medical Group

Napa, California, United States

Site Status

Unity Spine Center

Rochester, New York, United States

Site Status

Clinical Trials of South Carolina

Charleston, South Carolina, United States

Site Status

Wilhelminenspital Wien

Vienna, , Austria

Site Status

AZ Sint-Augustinus

Wilrijk, , Belgium

Site Status

Medizinische Einrichtungen der Universität Düsseldorf, Dusseldorf

Düsseldorf, , Germany

Site Status

Hospital Gera -Zentrum für interdisziplinäre Schmerztherapie, Gera

Gera, , Germany

Site Status

Azienda Ospedaliero Universitaria Pisana

Pisa, , Italy

Site Status

Hospital Virgen de Rocio

Seville, , Spain

Site Status

Seacroft Hospital

Leeds, Ykshre, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Austria Belgium Germany Italy Spain United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CRD_800

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Outcome Measure at Stryker Spine
NCT06226272 NOT_YET_RECRUITING
Spinal Cord Stimulation for Low Back Pain
NCT00205868 COMPLETED PHASE4
LUMBAR & SACROILIAC FUSION STUDY
NCT07204288 RECRUITING NA
Restore CLINICAL TRIAL
NCT01609374 UNKNOWN NA